Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

NCT06141369 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Adrenal Cortical Carcinoma
Medullary Thyroid Cancer
Thymic Neuroendocrine Carcinoma
Pancreatic Neuroendocrine Tumor

Interventions

BIOLOGICAL: individualized mRNA neoantigen vaccine (mRNA-0523-L001)

Sponsor

Shanghai Jiao Tong University School of Medicine